PSMAfore: Lu-PSMA for men with castrate-resistant prostate cancer

Clinical Trial Grant

Duke Scholars

Principal Investigator Daniel James George Medicine, Medical Oncology

Awarded By

Novartis Pharmaceuticals Corporation

Start Date

April 1, 2021

End Date

February 11, 2026

Awarded By

Novartis Pharmaceuticals Corporation

Start Date

April 1, 2021

End Date

February 11, 2026